Responsiveness of the University of California-Los Angeles Prostate Cancer Index

Urology

Volumn 75, Issue 6, 2010, Pages 1418-1423

  Bergman, Jonathan ^a   Saigal, Christopher S ^a   Kwan, Lorna ^a   Litwin, Mark S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN;

ADULT; ARTICLE; BLADDER FUNCTION; BRACHYTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; EFFECT SIZE; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HEALTH SURVEY; HUMAN; INTERMETHOD COMPARISON; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; QUALITY OF LIFE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEXUAL FUNCTION; SHORT FORM 36; UNIVERSITY OF CALIFORNIA LOS ANGELES PROSTATE CANCER INDEX;

ADENOCARCINOMA; AGE FACTORS; BRACHYTHERAPY; CALIFORNIA; DYSPAREUNIA; ERECTILE DYSFUNCTION; HEALTH SURVEYS; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; INTERPERSONAL RELATIONS; LOS ANGELES; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; SICKNESS IMPACT PROFILE; URINATION DISORDERS;

EID: 77952742885     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.04.070     Document Type: Article

References (30)

1. Guyatt G., Walter S., and Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 40 (1987) 171-178
2. Wiebe S., Guyatt G., Weaver B., et al. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 56 (2003) 52-60
3. Murawski M.M., and Miederhoff P.A. On the generalizability of statistical expressions of health related quality of life instrument responsiveness: a data synthesis. Qual Life Res 7 (1998) 11-22
4. Gacci M., Livi L., Paiar F., et al. Quality of life after radical treatment of prostate cancer: validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index. Urology 66 (2005) 338-343
5. Kakehi Y., Kamoto T., Ogawa O., et al. Development of Japanese version of the UCLA Prostate Cancer Index: a pilot validation study. Int J Clin Oncol 7 (2002) 306-311
6. Litwin M.S., Hays R.D., Fink A., et al. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 36 (1998) 1002-1012
7. Korfage I.J., Essink-Bot M.L., Madalinska J.B., et al. Measuring disease specific quality of life in localized prostate cancer: the Dutch experience. Qual Life Res 12 (2003) 459-464
8. Karakiewicz P.I., Kattan M.W., Tanguay S., et al. Cross-cultural validation of the UCLA prostate cancer index. Urology 61 (2003) 302-307
9. Krongrad A., Perczek R.E., Burke M.A., et al. Reliability of Spanish translations of select urological quality of life instruments. J Urol 158 (1997) 493-496
10. Litwin M.S., Hays R.D., Fink A., et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273 (1995) 129-135
11. Marks G.B., Dunn S.M., and Woolcock A.J. An evaluation of an asthma quality of life questionnaire as a measure of change in adults with asthma. J Clin Epidemiol 46 (1993) 1103-1111
12. McHorney C.A., Ware Jr. J.E., Lu J.F., et al. The MOS 36-item Short-Form Health Survey (SF-36).III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32 (1994) 40-66
13. Propert K.J., Litwin M.S., Wang Y., et al. Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res 15 (2006) 299-305
14. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36).I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
15. Walsh P.C. Anatomic radical prostatectomy: evolution of the surgical technique. J Urol 160 (1998) 2418-2424
16. Baguley T. Standardized or simple effect size: what should be reported?. Br J Psychol (2008) (in press)
17. Guyatt G.H., Berman L.B., Townsend M., et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax 42 (1987) 773-778
18. Kantz M.E., Harris W.J., Levitsky K., et al. Methods for assessing condition-specific and generic functional status outcomes after total knee replacement. Med Care 30 (1992) MS240-MS252
19. Mehta S.S., Lubeck D.P., Pasta D.J., et al. Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE. J Urol 170 (2003) 1931-1933
20. Miller D.C., Sanda M.G., Dunn R.L., et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol 23 (2005) 2772-2780
21. Wei J.T., Dunn R.L., Sandler H.M., et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 20 (2002) 557-566
22. Roth A.J., Rosenfeld B., Kornblith A.B., et al. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer. Cancer 97 (2003) 2910-2918
23. Lubeck D.P., Litwin M.S., Henning J.M., et al. Measurement of health-related quality of life in men with prostate cancer: the CaPSURE database. Qual Life Res 6 (1997) 385-392
24. Anderson R.U., Wise D., Sawyer T., et al. Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training. J Urol 176 (2006) 1534-1538 Discussion:1538-1539
25. Saigal C.S., Gornbein J., Nease R., et al. Predictors of utilities for health states in early stage prostate cancer. J Urol 166 (2001) 942-946
26. Saigal C.S., Gornbein J., Reid K., et al. Stability of time trade-off utilities for health states associated with the treatment of prostate cancer. Qual Life Res 11 (2002) 405-414
27. Litwin M.S., Gore J.L., Kwan L., et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 109 (2007) 2239-2247
28. Penson D.F., McLerran D., Feng Z., et al. 5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study. J Urol 179 (2008) S40-S44
29. Liang M.H. Longitudinal construct validity: establishment of clinical meaning in patient evaluative instruments. Med Care 38 (2000) II84-II90
30. Norman G.R., Stratford P., and Regehr G. Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. J Clin Epidemiol 50 (1997) 869-879